Berry C C, de la Fuente J M, Mullin M, Chu S Wai Ling, Curtis A S G
Centre for Cell Engineering, Institute of Biomedical and Life Sciences, University of Glasgow, UK.
IEEE Trans Nanobioscience. 2007 Dec;6(4):262-9. doi: 10.1109/tnb.2007.908973.
The impermeable nature of the cell plasma membrane limits the therapeutic uses of many macromolecules and there is therefore a growing effort to circumvent this problem by designing strategies for targeted intracellular delivery. During the last decade several cell penetrating peptides, such as the HIV-1 tat peptide, have been shown to traverse the cell membrane, where integral protein transduction domains (PTDs) are responsible for their cellular uptake, and to reach the nucleus while retaining biological activity. It has since been discovered that PTDs can enable the cellular delivery of conjugated biomolecules and even nanoparticles, but nuclear delivery has remained problematic. This present study focuses on the development of water soluble, biocompatible gold nanoparticles of differing size functionalized with the HIV-1 tat PTD with the aim of producing nuclear targeting agents. The particles were subsequently tested in vitro with a human fibroblast cell line, with results demonstrating successful nanoparticle transfer across the plasma membrane, with 5 nm particles achieving nuclear entry while larger 30 nm particles are retained in the cytoplasm, suggesting entry is blocked via nuclear pores dimensions.
细胞质膜的不可渗透性质限制了许多大分子的治疗用途,因此人们越来越努力通过设计靶向细胞内递送策略来规避这一问题。在过去十年中,几种细胞穿透肽,如HIV-1 tat肽,已被证明能穿过细胞膜,其中完整的蛋白质转导结构域(PTD)负责它们的细胞摄取,并在保持生物活性的同时到达细胞核。此后人们发现,PTD能够实现共轭生物分子甚至纳米颗粒的细胞递送,但细胞核递送仍然存在问题。本研究重点在于开发用HIV-1 tat PTD功能化的不同尺寸的水溶性、生物相容性金纳米颗粒,目的是制备核靶向剂。随后用人类成纤维细胞系对这些颗粒进行了体外测试,结果表明纳米颗粒成功穿过质膜,5纳米的颗粒进入细胞核,而较大的30纳米颗粒则保留在细胞质中,这表明进入过程因核孔尺寸而受阻。